Lineage Announces Research Collaboration to Develop ReSonance for Hearing Loss
Lineage Cell Therapeutics has entered into a $12 million research collaboration to advance its auditory neuronal cell transplant, ReSonance.
Lineage Cell Therapeutics has entered into a $12 million research collaboration to advance its auditory neuronal cell transplant, ReSonance.
HIA's MarkeTrak 2025 study of the U.S. hearing loss market provides new data on prescription hearing aids, OTC devices, and emerging technologies.
Beltone's new BTE rechargeable Super Power hearing aid is designed to deliver powerful amplification in a small package for individuals with severe-to-profound hearing loss while preventing unwanted feedback.
Researchers have adapted the low-cost OCT imaging method developed for ophthalmology and used it to visualize tiny structures in the human inner ear.
AI seems to be everywhere now, but are hearing care professionals ready to accept this new technology?
A bipartisan group of U.S. senators has reintroduced the Medicare Audiology Access Improvement Act to eliminate barriers preventing Medicare beneficiaries from directly accessing care from audiologists.